Literature DB >> 22982397

T-cell acute leukemia 1 (TAL1) regulation of erythropoietin receptor and association with excessive erythrocytosis.

Heather Rogers1, Li Wang, Xiaobing Yu, Mawadda Alnaeeli, Kairong Cui, Keji Zhao, James J Bieker, Josef Prchal, Suming Huang, Babette Weksler, Constance Tom Noguchi.   

Abstract

During erythropoiesis, erythropoietin stimulates induction of erythroid transcription factors that activate expression of erythroid genes including the erythropoietin receptor (EPO-R) that results in increased sensitivity to erythropoietin. DNA binding of the basic helix-loop-helix transcription factor, TAL1/SCL, is required for normal erythropoiesis. A link between elevated TAL1 and excessive erythrocytosis is suggested by erythroid progenitor cells from a patient that exhibits unusually high sensitivity to erythropoietin with concomitantly elevated TAL1 and EPO-R expression. We found that TAL1 regulates EPO-R expression mediated via three conserved E-box binding motifs (CAGCTG) in the EPO-R 5' untranslated transcribed region. TAL1 increases association of the GATA-1·TAL1·LMO2·LDB1 transcription activation complex to the region that includes the transcription start site and the 5' GATA and 3' E-box motifs flanking the EPO-R transcription start site suggesting that TAL1 promotes accessibility of this region. Nucleosome shifting has been demonstrated to facilitate TAL1 but not GATA-1 binding to regulate target gene expression. Accordingly, we observed that with induced expression of EPO-R in hemotopoietic progenitor cells, nucleosome phasing shifts to increase the linker region containing the EPO-R transcription start site and TAL1 binds to the flanking 5' GATA and 3' E-box regions of the promoter. These data suggest that TAL1 binds to the EPO-R promoter to activate EPO-R expression and provides a potential link to elevated EPO-R expression leading to hypersensitivity to erythropoietin and the resultant excessive erythrocytosis.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22982397      PMCID: PMC3481276          DOI: 10.1074/jbc.M112.378398

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  52 in total

1.  Functional but abnormal adult erythropoiesis in the absence of the stem cell leukemia gene.

Authors:  Mark A Hall; Nicholas J Slater; C Glenn Begley; Jessica M Salmon; Leonie J Van Stekelenburg; Matthew P McCormack; Stephen M Jane; David J Curtis
Journal:  Mol Cell Biol       Date:  2005-08       Impact factor: 4.272

Review 2.  Causes of oncogenic chromosomal translocation.

Authors:  Peter D Aplan
Journal:  Trends Genet       Date:  2005-10-28       Impact factor: 11.639

3.  Polycythemia vera is not initiated by JAK2V617F mutation.

Authors:  Roberto H Nussenzveig; Sabina I Swierczek; Jaroslav Jelinek; Amos Gaikwad; Enli Liu; Srdan Verstovsek; Jaroslav F Prchal; Josef T Prchal
Journal:  Exp Hematol       Date:  2007-01       Impact factor: 3.084

4.  Acquired mutation of the tyrosine kinase JAK2 in human myeloproliferative disorders.

Authors:  E Joanna Baxter; Linda M Scott; Peter J Campbell; Clare East; Nasios Fourouclas; Soheila Swanton; George S Vassiliou; Anthony J Bench; Elaine M Boyd; Natasha Curtin; Mike A Scott; Wendy N Erber; Anthony R Green
Journal:  Lancet       Date:  2005 Mar 19-25       Impact factor: 79.321

5.  A family with erythrocytosis establishes a role for prolyl hydroxylase domain protein 2 in oxygen homeostasis.

Authors:  Melanie J Percy; Quan Zhao; Adrian Flores; Claire Harrison; Terence R J Lappin; Patrick H Maxwell; Mary Frances McMullin; Frank S Lee
Journal:  Proc Natl Acad Sci U S A       Date:  2006-01-09       Impact factor: 11.205

6.  beta-Trcp mediates ubiquitination and degradation of the erythropoietin receptor and controls cell proliferation.

Authors:  Laure Meyer; Bénédicte Deau; Hana Forejtníková; Dominique Duménil; Florence Margottin-Goguet; Catherine Lacombe; Patrick Mayeux; Frédérique Verdier
Journal:  Blood       Date:  2007-02-27       Impact factor: 22.113

7.  Generation of committed erythroid BFU-E and CFU-E progenitors does not require erythropoietin or the erythropoietin receptor.

Authors:  H Wu; X Liu; R Jaenisch; H F Lodish
Journal:  Cell       Date:  1995-10-06       Impact factor: 41.582

8.  Novel binding partners of Ldb1 are required for haematopoietic development.

Authors:  Natalia Meier; Sanja Krpic; Patrick Rodriguez; John Strouboulis; Maria Monti; Jeroen Krijgsveld; Martin Gering; Roger Patient; Arnd Hostert; Frank Grosveld
Journal:  Development       Date:  2006-11-15       Impact factor: 6.868

9.  JAK2 exon 12 mutations in polycythemia vera and idiopathic erythrocytosis.

Authors:  Linda M Scott; Wei Tong; Ross L Levine; Mike A Scott; Philip A Beer; Michael R Stratton; P Andrew Futreal; Wendy N Erber; Mary Frances McMullin; Claire N Harrison; Alan J Warren; D Gary Gilliland; Harvey F Lodish; Anthony R Green
Journal:  N Engl J Med       Date:  2007-02-01       Impact factor: 91.245

10.  ETO-2 associates with SCL in erythroid cells and megakaryocytes and provides repressor functions in erythropoiesis.

Authors:  Anna H Schuh; Alex J Tipping; Allison J Clark; Isla Hamlett; Boris Guyot; Francesco J Iborra; Patrick Rodriguez; John Strouboulis; Tariq Enver; Paresh Vyas; Catherine Porcher
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

View more
  7 in total

1.  Mice over-expressing human erythropoietin indicate that erythropoietin enhances expression of its receptor via up-regulated Gata1 and Tal1.

Authors:  Philipp Deindl; Martin Klar; David Drews; Malte Cremer; Elena Gammella; Max Gassmann; Christof Dame
Journal:  Haematologica       Date:  2014-08-01       Impact factor: 9.941

2.  Novel compound VHL heterozygosity (VHL T124A/L188V) associated with congenital polycythaemia.

Authors:  Felipe R Lorenzo; Chunzhang Yang; Lucie Lanikova; Linda Butros; Zhengping Zhuang; Josef T Prchal
Journal:  Br J Haematol       Date:  2013-06-17       Impact factor: 6.998

3.  The DEK Oncoprotein Is a Critical Component of the EKLF/KLF1 Enhancer in Erythroid Cells.

Authors:  Felix Lohmann; Mohan Dangeti; Shefali Soni; Xiaoyong Chen; Antanas Planutis; Margaret H Baron; Kyunghee Choi; James J Bieker
Journal:  Mol Cell Biol       Date:  2015-08-24       Impact factor: 4.272

Review 4.  The Many Facets of Erythropoietin Physiologic and Metabolic Response.

Authors:  Sukanya Suresh; Praveen Kumar Rajvanshi; Constance T Noguchi
Journal:  Front Physiol       Date:  2020-01-17       Impact factor: 4.566

5.  Data-driven modeling predicts gene regulatory network dynamics during the differentiation of multipotential hematopoietic progenitors.

Authors:  Joanna E Handzlik
Journal:  PLoS Comput Biol       Date:  2022-01-14       Impact factor: 4.475

Review 6.  Erythropoietin action in stress response, tissue maintenance and metabolism.

Authors:  Yuanyuan Zhang; Li Wang; Soumyadeep Dey; Mawadda Alnaeeli; Sukanya Suresh; Heather Rogers; Ruifeng Teng; Constance Tom Noguchi
Journal:  Int J Mol Sci       Date:  2014-06-10       Impact factor: 5.923

7.  Transcriptomics of Long-Term Meditation Practice: Evidence for Prevention or Reversal of Stress Effects Harmful to Health.

Authors:  Supaya Wenuganen; Kenneth G Walton; Shilpa Katta; Clifton L Dalgard; Gauthaman Sukumar; Joshua Starr; Frederick T Travis; Robert Keith Wallace; Paul Morehead; Nancy K Lonsdorf; Meera Srivastava; John Fagan
Journal:  Medicina (Kaunas)       Date:  2021-03-01       Impact factor: 2.430

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.